Abstract
During the past 20 yr, molecular biology and molecular genetics have provided techniques and procedures that allow the precise diagnoses of leukemias and lymphomas (for a review, see ref. 1). These methodologies have provided powerful, robust, and precise characterizations of genetic mutations and gene rearrangements (both normal and abnormal) that have been applied to the diagnosis and treatment of these malignancies. In this chapter we discuss methodologies currently utilized within the molecular diagnostic laboratory of cancer centers and major academic hospitals. We introduce these methodologies in both general terms and within the context of a differential diagnosis of leukemia/lymphoma. The long-term goal of the molecular hematologist/oncologist is to describe all mutations that occur within a given type or subtype of leukemia/lymphoma. This involves the discovery of new somatic and possibly hereditary mutations that contribute to the genesis of these hematologic malignancies. However, for this information to be useful in treatment regimens, therapies that target or affect these growth-dysregulating mutations must be found. Because diagnosis of mutation and gene rearrangement in the hematologic malignancies is far ahead of therapeutic modalities, we also discuss new research tools that will have impact on the experimental hematologist.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kinniburgh, A. J. and Ward, P. M. (1977) The application of molecular genetics and biology to the diagnosis and treatment of cancer. Adv. Oncol. 13, 3–8.
Tonegawa, S. (1983) Somatic generation of antibody diversity. Nature 302, 575–581.
Hood, L., Kronenberg, M., and Hunkapiller, T. (1985) T cell antigen receptors and the immunoglobulin supergene family. Cell 40, 225–229.
Korsmeyer, S. J. (1988) B-lymphoid neoplasias: immunoglobulin genes are molecular determinants of clonality lineage, differentiation and translocation. Adv. Intern. Med. 33, 1–15.
van Dongen, J. M. J. and Wolvers-Tettero, I. L. M. (1991) Analysis of immunoglobulin and T cell receptor genes. Part 1: basic and technical aspects. Clin. Chim. Acta 198, 1–92.
Hieter, P. A., Korsmeyer, S. J., Waldmann, T. A., et al. (1981) Human immunoglobulin K light-chain genes are deleted or rearranged in lambda-producing B cells. Nature 290, 369–372.
Groffen, J., Stephenson, J. R., Hersterkamp, N., et al. (1990) Philadelphia chromosome breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36, 93–99.
Sawyers, C. L., Timson, L., Kawasaki, E. S., et al. (1990) Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detect by polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87, 563–567.
Yunis, J. J. (1983) The chromosomal basis of human neoplasia. Science 221, 227–236.
Levine, E. G., Arthur, D. C., Fizzera, G., et al. (1985) There are differences in cytogenetic abnormalities among histologic subtypes of non-Hodgkin’s lympoma. Blood 66, 1414–1422.
Lipford, E., Wright, J. J., Urba, W., et al. (1987) Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint region. Blood 70, 1816–1823.
Bakhshi, A., Wright, J. J., Graininger, W., et al. (1987) Mechanism of the t(14;18) chromosomal translocation: structural analyses of both derivative 14 and 18 reciprocal partners. Proc. Natl. Acad. Sci. USA 84, 2396–2400.
Lee, M. S., Chang, K. S., Cabanillas, F., et al. (1987) Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science 237, 175–178.
Ngan, B. Y., Nourse, J., and Cleary, M. L. (1989) Detection of chromosomal translocation t(14; 18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas. Blood 73, 1759–1762.
Gribben, J. G., Freedman, A. S., Woo, S. D., et al. (1991) All advanced stage nonHodgkin’s lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78, 3275–3280.
Gribben, J. G., Neuberg, D., Barber, M., et al. (1994) Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83, 3800–3807.
Pezzella, F. Ralfkiaer, E., Gatter, K. C., and Mason, D. Y. (1990) The 14;18 translocation in European cases of follicular lymphoma: comparison of southern blotting and the polymerase chain reaction. Br. J. Haematol. 76, 58–64.
Tsujimoto, Y., Bashir, M. M., Givol, I., et al. (1987) DNA rearrangements in human follicular lymphoma can involve the 5? or 3? region of the bcl-2 gene. Proc. Natl. Acad. Sci. USA 84, 1329–1331.
Pezzella, F., Jones, M., Ralfkiaer, E., et al. (1992) Evaluation of bcl-2 protein expression and 14; 18 translocation as prognostic markers in follicular lymphoma. Br. J. Cancer 65, 87–89.
Gribben, J. G., Neuberg, D., Freedman, A. S., et al. (1993) Detection by poly-merase chain reaction of residual cells with bcl-2 translocation is associated with increased risk of relapse after autologous bone marrowtransplantation for B-cell lymphoma. Blood 81, 3449–3457.
Moore, J. S., Friedman, D. F., Silberstein, L. E., et al. (1995) Clinical heterogene-ity reflects biologic diversity in chronic lymphocytic leukemia. Crit. Rev. Oncol. Hematol. 20, 141–164.
Schena, M., Gottardi, D., Ghia, P., et al. (1993) The role of Bcl-2 in the pathogenesis of Bcl-2 in the pathogenesis of B chronic lymphocytic leukemia. Leuk. Lymphoma 11, 173–179.
Hanada, M., Delia, D., Aiello, A., et al. (1993) Bcl-2 gene hypomethylation and highlevel expression in B-cell chronic lymphocytic leukemia. Blood 82, 1820–1828.
Sawyers, C. L., Timson, L., Kawaski, E. S., et al. (1990) Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87, 563–567.
Mitani, K. (1996) Chromosomal abnormalities and oncogenes. Int. J. Hematol. 63, 81–93.
Drexler, H. G., Borkhardt, A., and Jansen, J. W. (1995) Detection of chromosomal translocation in leukemia-lymphoma cells by polymerase chain reaction. Leuk. Lymphoma 19, 59–80.
Miyake, K., Inokuchi, K., Dan, K., and Nomura, T. (1993) Alterations in the deleted in colorectal cancer gene in human, primary leukemia. Blood 82, 927–930.
Velculescu, V. E., Zhang, L., Vogelstein, B., and Kinzler, K. W. (1995) Serial analysis of gene expression. Science 270, 484–487.
Zhang, L., Zhow, W., Velculescu, V. E., Hern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. (1997) Gene expression profiles in normal and cancer cells. Science 276, 1268–1272.
Del Sal, G., Manfiolette, G., and Schneider, C. (1989) The CTAB-DNA precipitation method: a common mini-scale preparation of template DNA from phagemids, phages or plasmids suitable for sequencing. Biotechniques 7, 514–519.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Beishuizen, A. Verhoeven, M.-A. J., Mol, E. J., Breit, T. M., WolversTettero, I. L. M., and van Dongen, J. J. M. (1993) Detection of immunoglobulin heavy-chain gene rearrangements by southern blot analysis: recommendations for optimal results. Leukemia 7, 2045–2053.
Silva, A. J., Johnson, J. P., and White, R. L. (1987) Characterization of a highly polymorphic region 5? to JH in the human immunoglobulin heavy chain. Nucleic Acid Res. 15, 2845–2857.
Limpens, J., de Jong, D., van Krieken, J. H., et al. (1991) Bc1-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6, 2271–2276.
Limpens, J., Stad, R., Vos, C., et al. (1995) Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 85, 2528–2536.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Ward, P., Kinniburgh, A. (2001). Molecular Genetic Methods in Diagnosis and Treatment. In: Faguet, G.B. (eds) Hematologic Malignancies. Methods in Molecular Medicine™, vol 55. Humana Press. https://doi.org/10.1385/1-59259-074-8:83
Download citation
DOI: https://doi.org/10.1385/1-59259-074-8:83
Publisher Name: Humana Press
Print ISBN: 978-0-89603-543-0
Online ISBN: 978-1-59259-074-2
eBook Packages: Springer Protocols